Virtu Financial LLC Anavex Life Sciences Corp. Transaction History

Virtu Financial LLC

  • $1.79 Billion
  • Q3 2025

A detailed history of Virtu Financial LLC transactions in Anavex Life Sciences Corp. stock. As of the latest transaction made, Virtu Financial LLC holds 12,859 shares of AVXL stock, worth $46,806. This represents 0.01% of its overall portfolio holdings.

Number of Shares
12,859
Holding current value
$46,806
% of portfolio
0.01%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
BUY
$8.44 - $13.41 $108,529 - $172,439
12,859 New
12,859 $114,000
Q1 2025

May 12, 2025
SELL
$7.85 - $13.46 $503,491 - $863,310
-64,139 Reduced 71.24%
25,895 $222,000
Q4 2024

Feb 11, 2025
BUY
$5.11 - $12.56 $460,073 - $1.13 Million
90,034 New
90,034 $967,000
Q1 2024

May 20, 2024
BUY
$4.55 - $6.75 $86,240 - $127,939
18,954 Added 87.52%
40,612 $207,000
Q4 2023

Feb 26, 2024
BUY
$5.04 - $9.95 $109,156 - $215,497
21,658 New
21,658 $202,000
Q2 2023

Jul 27, 2023
SELL
$7.66 - $9.5 $435,532 - $540,151
-56,858 Reduced 83.17%
11,507 $94,000
Q1 2023

May 01, 2023
BUY
$8.32 - $11.75 $322,408 - $455,324
38,751 Added 130.85%
68,365 $586,000
Q4 2022

Feb 15, 2023
BUY
$7.65 - $14.43 $226,547 - $427,330
29,614 New
29,614 $274,000
Q1 2022

May 17, 2022
SELL
$9.74 - $17.69 $151,194 - $274,601
-15,523 Closed
0 $0
Q4 2021

Feb 17, 2022
BUY
$16.88 - $23.31 $262,028 - $361,841
15,523 New
15,523 $269,000
Q3 2021

Nov 12, 2021
SELL
$16.82 - $25.75 $1.36 Million - $2.09 Million
-81,011 Closed
0 $0
Q2 2021

Sep 17, 2021
BUY
$10.16 - $28.86 $823,071 - $2.34 Million
81,011 New
81,011 $1.85 Million
Q1 2021

May 19, 2021
SELL
$5.17 - $16.13 $77,808 - $242,756
-15,050 Closed
0 $0
Q4 2020

Feb 24, 2021
SELL
$4.01 - $7.58 $62,940 - $118,975
-15,696 Reduced 51.05%
15,050 $81,000
Q3 2020

Dec 11, 2020
BUY
$3.8 - $5.0 $67,803 - $89,215
17,843 Added 138.29%
30,746 $140,000
Q2 2020

Aug 07, 2020
SELL
$2.62 - $5.2 $55,103 - $109,366
-21,032 Reduced 61.98%
12,903 $63,000
Q4 2019

Feb 04, 2020
SELL
$2.31 - $3.14 $38,124 - $51,822
-16,504 Reduced 32.72%
33,935 $88,000
Q3 2019

Nov 20, 2019
BUY
$2.22 - $3.9 $111,974 - $196,712
50,439 New
50,439 $159,000
Q2 2019

Aug 13, 2019
SELL
$2.75 - $3.7 $136,345 - $183,446
-49,580 Closed
0 $0
Q1 2019

Apr 12, 2019
BUY
$1.68 - $3.42 $83,294 - $169,563
49,580 New
49,580 $152,000
Q4 2017

Feb 09, 2018
SELL
$3.12 - $4.94 $76,973 - $121,874
-24,671 Closed
0 $0
Q3 2017

Nov 15, 2017
BUY
$3.42 - $4.87 $84,374 - $120,147
24,671
24,671 $0

Others Institutions Holding AVXL

# of Institutions
211
Shares Held
32.1M
Call Options Held
1.82M
Put Options Held
1.09M
View Full List

About ANAVEX LIFE SCIENCES CORP.

AVXL Quotes by TradingView
  • Ticker AVXL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,942,800
  • Market Cap $284M
  • Description
  • Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...
More about AVXL
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email